Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2007-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00699-07PMID 17938191PMCID PMC2223904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard

  2008cited by this paper
• Serum Differentially Alters the Antifungal Properties of Echinocandin Drugs

  2007cited by this paper
• Paradoxical Effect of Echinocandins across Candida Species In Vitro: Evidence for Echinocandin-Specific and Candida Species-Related Differences

  2007cited by this paper
• Efficacy of Caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans

  2006cited by this paper
• Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species.

  2006cited by this paper
• Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

  2006cited by this paper
• Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species

  2006influential reference
• The Echinocandins: Comparison of Their Pharmacokinetics, Pharmacodynamics and Clinical Applications

  2006cited by this paper
• Escape of Candida from Caspofungin Inhibition at Concentrations above the MIC (Paradoxical Effect) Accomplished by Increased Cell Wall Chitin; Evidence for β-1,6-Glucan Synthesis Inhibition by Caspofungin

  2006cited by this paper
• Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus Infection

  2006cited by this paper
• Effect of Voriconazole Combined with Micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani

  2005cited by this paper
• Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin.

  2005cited by this paper
• Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.

  2005cited by this paper
• Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity.

  2004cited by this paper
• Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

  2004cited by this paper
• Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus.

  2004cited by this paper
• Paradoxical Effect of Caspofungin: Reduced Activity against Candida albicans at High Drug Concentrations

  2004cited by this paper
• Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

  2004cited by this paper
• Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting

  2004cited by this paper
• Echinocandin antifungal drugs.

  2003cited by this paper
• In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.

  2003cited by this paper
• Interlaboratory Evaluation of Hematocytometer Method of Inoculum Preparation for Testing Antifungal Susceptibilities of Filamentous Fungi

  2003cited by this paper
• Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)

  2003cited by this paper
• The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

  2003cited by this paper
• In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus andFusarium Isolates

  2001cited by this paper
• The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus.

  2001cited by this paper
• 1,3-beta-Glucan synthase: a useful target for antifungal drugs.

  2001cited by this paper
• Comparison of Spectrophotometric and Visual Readings of NCCLS Method and Evaluation of a Colorimetric Method Based on Reduction of a Soluble Tetrazolium Salt, 2,3-Bis {2-Methoxy-4-Nitro-5-[(Sulfenylamino) Carbonyl]-2H- Tetrazolium-Hydroxide}, for Antifungal Susceptibility Testing of AspergillusSpeci

  2001cited by this paper
• Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus.

  1999cited by this paper
• In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.

  1998cited by this paper
• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

  1998cited by this paper
• Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

  1994cited by this paper
• Morphological Effects of Lipopeptides against Aspergillus fumigatus Correlate with Activities against (1,3)-β-d-Glucan Synthase

  1994cited by this paper

• Usage of Antifungal Agents in Pediatric Patients Versus Adults: Knowledge and Gaps

  2024cites this paper
• Various Biomimetics, Including Peptides as Antifungals

  2023cites this paper
• Genomic and Molecular Identification of Genes Contributing to the Caspofungin Paradoxical Effect in Aspergillus fumigatus

  2022cites this paper
• Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation

  2021cites this paper
• Comparative Pharmacodynamics of Echinocandins against Aspergillus fumigatus Using an In Vitro Pharmacokinetic/Pharmacodynamic Model That Correlates with Clinical Response to Caspofungin Therapy: Is There a Place for Dose Optimization?

  2021cites this paper
• The Composition of the Culture Medium Influences the (cid:12) -1,3-Glucan Metabolism of Aspergillus fumigatus and the Antifungal Activity of Inhibitors of (cid:12) -1,3-Glucan Synthesis

  2020influential citation
• The Eagle Effect and Antibiotic-Induced Persistence: Two Sides of the Same Coin?

  2019cites this paper
• Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside

  2019cites this paper
• Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies

  2018cites this paper
• A New Marker of Echinocandin Activity in an In Vitro Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus Infection

  2018cites this paper
• Genomics‐driven discovery of a novel self‐resistance mechanism in the echinocandin‐producing fungus Pezicula radicicola

  2018cites this paper
• Filter Adsorption of Anidulafungin to a Polysulfone‐Based Hemofilter During CVVHD In Vitro

  2018cites this paper
• The cellular and molecular responses of Aspergillus fumigatus to the antifungal drug caspofungin

  2018cites this paper
• Ampliación y validación de una nueva base de datos para la identificación de Aspergillus SPP. Mediante EM MALDI-TOF.

  2018cites this paper
• Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins

  2017cites this paper
• Use of Novel Tools to Probe Drug Resistance in Fungi

  2017cites this paper
• CLSI M 38A 2 reference method 1 for antifungal susceptibility testing of Aspergillus spp . against echinocandins 2 3

  2017cites this paper
• Caspofungin Increases Fungal Chitin and Eosinophil and γδ T Cell–Dependent Pathology in Invasive Aspergillosis

  2017cites this paper
• This information is current as Pathology in Invasive Aspergillosis Dependent − T Cell δγ Eosinophil and Caspofungin Increases Fungal Chitin and

  2017cites this paper
• Recent Insights into the Paradoxical Effect of Echinocandins

  2017influential citation
• In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil

  2017cites this paper
• Antibiotic Dosing During Continuous Renal Replacement Therapy (CRRT)

  2016cites this paper
• Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes

  2016influential citation
• Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis.

  2016cites this paper
• Echinocandins: The Expanding Antifungal Armamentarium.

  2015cites this paper
• Potential Microbiological Effects of Higher Dosing of Echinocandins.

  2015cites this paper
• Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies

  2015cites this paper
• Trailing or paradoxical growth of Aspergillus flavus exposed to caspofungin is independent of genotype.

  2014cites this paper
• Micafungin for the treatment of invasive aspergillosis.

  2014cites this paper
• Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration.

  2014cites this paper
• Pharmacokinetics and Safety of Intravitreal Caspofungin

  2014cites this paper
• Antimicrobial dosing in acute renal replacement.

  2013cites this paper
• The pharmacodynamics of antifungal agents against Aspergillus

  2013cites this paper
• Activity of antifungal combinations against Aspergillus species evaluated by isothermal microcalorimetry.

  2013cites this paper
• Amphotericin B- and Voriconazole-Echinocandin Combinations against Aspergillus spp.: Effect of Serum on Inhibitory and Fungicidal Interactions

  2013cites this paper
• The Eagle-like effect of echinocandins: what’s in a name?

  2013cites this paper
• Inhibitory and Fungicidal Effects of Antifungal Drugs against Aspergillus Species in the Presence of Serum

  2013cites this paper
• Influence of Serum and Albumin on Echinocandin In Vitro Potency and Pharmacodynamics

  2013cites this paper
• Susceptibility Screening of Hyphae-Forming Fungi with a New, Easy, and Fast Inoculum Preparation Method

  2012cites this paper
• Echinocandin Antifungal Drugs in Fungal Infections

  2012influential citation
• The Composition of the Culture Medium Influences the β-1,3-Glucan Metabolism of Aspergillus fumigatus and the Antifungal Activity of Inhibitors of β-1,3-Glucan Synthesis

  2012cites this paper
• Microcolony Imaging of Aspergillus fumigatus Treated with Echinocandins Reveals Both Fungistatic and Fungicidal Activities

  2012cites this paper
• Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.

  2012cites this paper
• Erratum to: Echinocandin antifungal drugs in fungal infections: a comparison

  2012influential citation
• Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins

  2012cites this paper
• Synthesis -1,3-Glucan β Activity of Inhibitors of Aspergillus fumigatus and the Antifungal -1,3-Glucan Metabolism of β Influences the The Composition of the Culture Medium

  2012cites this paper
• Evaluation of Amphotericin B and Micafungin Combination Against Clinical Isolates of Aspergillus Species

  2011cites this paper
• The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.

  2011cites this paper
• [Echinocandins in children].

  2011cites this paper
• In vitro susceptibility of Aspergillus to echinocandins: Isolates from patients enrolled in the

  2011cites this paper
• Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.

  2011cites this paper
• Polyphasic Identification and Susceptibility to Seven Antifungals of 102 Aspergillus Isolates Recovered from Immunocompromised Hosts in Greece

  2011cites this paper
• Micafungin use in children

  2011cites this paper
• Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?

  2011cites this paper
• Caspofungin therapy in immunocompromised children and neonates

  2011cites this paper
• In Vitro Echinocandin Susceptibility of Aspergillus Isolates from Patients Enrolled in the Transplant-Associated Infection Surveillance Network

  2011cites this paper
• Current Role of Echinocandins in the Management of Invasive Aspergillosis

  2011cites this paper
• The elucidation of signalling and survival mechanisms of fungi to counteract the antifungal protein AFP

  2011cites this paper
• Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections

  2010cites this paper
• Role of Trehalose Biosynthesis in Aspergillus fumigatus Development, Stress Response, and Virulence

  2010cites this paper
• Fungal echinocandin resistance

  2010cites this paper
• Liposomal Amphotericin B and Echinocandins as Monotherapy or Sequential or Concomitant Therapy in Murine Disseminated and Pulmonary Aspergillus fumigatus Infections

  2010influential citation
• Profiling the Aspergillus fumigatus Proteome in Response to Caspofungin

  2010cites this paper
• A Clinical Review of Echinocandins in Pediatric Patients

  2010cites this paper
• Echinocandin pharmacodynamics: review and clinical implications.

  2010cites this paper
• Fungal echinocandin resistance

  2010cites this paper
• Transcriptional Regulation of Chitin Synthases by Calcineurin Controls Paradoxical Growth of Aspergillus fumigatus in Response to Caspofungin

  2010cites this paper
• Caspofungin

  2009cites this paper
• [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].

  2009cites this paper
• Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.

  2009influential citation
• Paradoxical echinocandin activity: a limited in vitro phenomenon?

  2009cites this paper
• Biofilm Formation in Aspergillus fumigatus

  2009cites this paper
• Micafungin in the treatment of invasive candidiasis and invasive aspergillosis

  2009cites this paper
• Activity Profile In Vitro of Micafungin against Spanish Clinical Isolates of Common and Emerging Species of Yeasts and Molds

  2009influential citation
• New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance

  2009cites this paper
• Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults

  2009cites this paper
• Echinocandins for prevention and treatment of invasive fungal infections

  2009cites this paper
• Papel futuro de la micafungina en el tratamiento de las micosis invasoras por hongos filamentosos

  2009cites this paper
• In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method

  2009influential citation
• Anidulafungin in Combination with Amphotericin B against Aspergillus fumigatus

  2009cites this paper
• Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.

  2009cites this paper
• Bronchopulmonary Disposition of Micafungin in Healthy Adult Volunteers

  2008influential citation
• Anidulafungin: a drug evaluation of a new echinocandin

  2008influential citation
• [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].

  2008cites this paper
• Actividad in vitro de anidulafungina. Comparación con la actividad de otras equinocandinas

  2008cites this paper
• Efecto de la unión a proteínas en la actividad de voriconazol solo o combinado con anidula-fungina frente Aspergillus spp . mediante cur

  year unknowncites this paper